Cargando…

Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?

Detalles Bibliográficos
Autores principales:	Kondoh, Hiroshi, Castellvi, Josep, LLeonart, Matilde Esther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072108/ https://www.ncbi.nlm.nih.gov/pubmed/33912471 http://dx.doi.org/10.3389/fonc.2021.671222

Ejemplares similares

Editorial: Sphingolipid metabolism and cancer
por: Ivanova, Margarita M., et al.
Publicado: (2022)

The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)

Autophagy Takes Center Stage as a Possible Cancer Hallmark
por: Alvarez-Meythaler, Jose G., et al.
Publicado: (2020)

Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
por: Benavente, Sergi, et al.
Publicado: (2020)

Hypoxia-Independent Drivers of Melanoma Angiogenesis
por: Meierjohann, Svenja
Publicado: (2015)

Editorial: Angiogenesis and tumor metastasis
por: Zhang, Qiang-Zhe, et al.
Publicado: (2023)

Senescence induction; a possible cancer therapy
por: LLeonart, Matilde E, et al.
Publicado: (2009)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
por: López-Camarillo, César, et al.
Publicado: (2020)

Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer
por: Passardi, Alessandro, et al.
Publicado: (2023)

Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals
por: Feliciano, Andrea, et al.
Publicado: (2020)

MicroRNAs Regulate Key Effector Pathways of Senescence
por: Feliciano, Andrea, et al.
Publicado: (2011)

Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021)

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
por: Li, Xiushen, et al.
Publicado: (2023)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Editorial: Tumor Hypoxia: Impact in Tumorigenesis, Diagnosis, Prognosis, and Therapeutics
por: Gomez, Christian R.
Publicado: (2016)

miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9
por: Feliciano, Andrea, et al.
Publicado: (2013)

Tumor Profiling at the Service of Cancer Therapy
por: Fernandez-Rozadilla, Ceres, et al.
Publicado: (2021)

Role of Metformin and AKT Axis Modulation in the Reversion of Hypoxia Induced TMZ-Resistance in Glioma Cells
por: Lo Dico, Alessia, et al.
Publicado: (2019)

Editorial: The role of one-carbon metabolism in cancer progression, therapy, and resistance
por: Thakur, Abhimanyu, et al.
Publicado: (2023)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
por: McDonald, Paul C., et al.
Publicado: (2016)

Imaging hypoxia in endometrial cancer: How and why should it be done?
por: deSouza, Nandita M., et al.
Publicado: (2022)

Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches
por: Singh, Manjari, et al.
Publicado: (2023)

Editorial: Extracellular vesicles as modulators of cancer cell adaptive responses linked to therapy resistance
por: Giordano, Antonio, et al.
Publicado: (2022)

Knockdown of m6A Reader IGF2BP3 Inhibited Hypoxia-Induced Cell Migration and Angiogenesis by Regulating Hypoxia Inducible Factor-1α in Stomach Cancer
por: Jiang, Libin, et al.
Publicado: (2021)

Editorial: Targeting cancer cell intracellular metabolism as a strategy against therapy resistance
por: Liu, Lingling, et al.
Publicado: (2023)

Editorial: Metabolic Rewiring in Leukemias
por: Noguera, Nelida I., et al.
Publicado: (2021)

Editorial: Metabolic Plasticity of Cancer
por: Rodríguez-Enríquez, Sara, et al.
Publicado: (2020)

Editorial: Reviews in cancer metabolism
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2023)

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
por: Adeshakin, Funmilayo O., et al.
Publicado: (2021)

Editorial: Targeting metabolism of cancer cells and host to overcome drug resistance: Preclinical and clinical studies
por: Wang, Lishun, et al.
Publicado: (2023)

Editorial: Redox metabolism: a double edge sword sustaining the adaptive resistance to therapy in cancer
por: Marengo, Barbara, et al.
Publicado: (2023)

Editorial: Neuroprotection in Brain Hypoxia
por: Otero-Losada, Matilde, et al.
Publicado: (2019)

Editorial: Metabolism As a Therapeutic Target
por: Columbano, Amedeo, et al.
Publicado: (2017)

Editorial: Redox and Metabolic Circuits in Cancer
por: Rizza, Salvatore, et al.
Publicado: (2018)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: Metabolism Meets Function: The Multifaced Role of Metabolism in Cancer
por: Giacomini, Isabella, et al.
Publicado: (2022)

Editorial: Current innovations in GI-oncology: Where do we stand?
por: Rumpold, Holger, et al.
Publicado: (2022)

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
por: de Leeuw, Renée, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l2fu0am5crr2ahc7a7t76rnuu8